Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study

Alison Edelman, Jeffrey Jensen, Sara McCrimmon, Marci Messerle-Forbes, Andrea O'Donnell, Jon Hennebold

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To determine if a combined oral contraceptive (COC) initiated shortly after ulipristal acetate (UPA) administration interferes with its mechanism of action. Study design: Healthy, reproductive-age women of normal BMI with proven ovulation (serum progesterone >3 ng/ml) were enrolled for three cycles (Cycle 1, UPA only; Cycle 2 washout; Cycle 3 UPA plus COC). During Cycles 1 and 3, subjects were monitored with transvaginal ultrasound and blood sampling for progesterone and LH every other day until a dominant follicle measuring >15 mm was visualized. In both treatment cycles, subjects received UPA (30mg) and were followed daily with similar monitoring for up to 7 days. In Cycle 3 only, subjects initiated a daily COC (0.15 mg levonorgestrel/30 μg ethinyl estradiol) 2 days after UPA. The study had 80% power to detect a 15% difference in the proportion of cycles with at least a 5-day delay in follicle rupture. We assessed follicle rupture as >50% decrease in mean size and adjudicated unclear outcomes with serum hormones. Results: A total of 36 women enrolled and 33 completed all study procedures [age 28.4 years (SD 3.9); BMI 23.4 (SD 2.4)]. Compared to Cycle 1, more subjects demonstrated evidence of follicle rupture in <5 days in Cycle 3 [1/33 (3%) vs. 9/33 (27%), p =.008]. We also included data from 2 subjects who experienced rupture prior to COC dosing in the analysis. Conclusion: UPA's effectiveness is significantly reduced by administering COCs 2 days later. Implications: This study demonstrates that UPA's efficacy as an emergency contraceptive is reduced with early exposure to COCs.

Original languageEnglish (US)
Pages (from-to)463-466
Number of pages4
JournalContraception
Volume98
Issue number6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Contraceptives, Oral, Combined
Ovulation
Cohort Studies
Prospective Studies
Rupture
Progesterone
Postcoital Contraceptives
Levonorgestrel
Ethinyl Estradiol
Serum
ulipristal acetate
Hormones

Keywords

  • Contraceptive initiation
  • Emergency contraception
  • Oral contraceptives
  • Ovulation inhibition
  • Pharmacodynamics
  • Ulipristal acetate

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation : A prospective cohort study. / Edelman, Alison; Jensen, Jeffrey; McCrimmon, Sara; Messerle-Forbes, Marci; O'Donnell, Andrea; Hennebold, Jon.

In: Contraception, Vol. 98, No. 6, 01.12.2018, p. 463-466.

Research output: Contribution to journalArticle

@article{f33d36d7be414f1e88ace7988c5d155b,
title = "Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study",
abstract = "Objective: To determine if a combined oral contraceptive (COC) initiated shortly after ulipristal acetate (UPA) administration interferes with its mechanism of action. Study design: Healthy, reproductive-age women of normal BMI with proven ovulation (serum progesterone >3 ng/ml) were enrolled for three cycles (Cycle 1, UPA only; Cycle 2 washout; Cycle 3 UPA plus COC). During Cycles 1 and 3, subjects were monitored with transvaginal ultrasound and blood sampling for progesterone and LH every other day until a dominant follicle measuring >15 mm was visualized. In both treatment cycles, subjects received UPA (30mg) and were followed daily with similar monitoring for up to 7 days. In Cycle 3 only, subjects initiated a daily COC (0.15 mg levonorgestrel/30 μg ethinyl estradiol) 2 days after UPA. The study had 80{\%} power to detect a 15{\%} difference in the proportion of cycles with at least a 5-day delay in follicle rupture. We assessed follicle rupture as >50{\%} decrease in mean size and adjudicated unclear outcomes with serum hormones. Results: A total of 36 women enrolled and 33 completed all study procedures [age 28.4 years (SD 3.9); BMI 23.4 (SD 2.4)]. Compared to Cycle 1, more subjects demonstrated evidence of follicle rupture in <5 days in Cycle 3 [1/33 (3{\%}) vs. 9/33 (27{\%}), p =.008]. We also included data from 2 subjects who experienced rupture prior to COC dosing in the analysis. Conclusion: UPA's effectiveness is significantly reduced by administering COCs 2 days later. Implications: This study demonstrates that UPA's efficacy as an emergency contraceptive is reduced with early exposure to COCs.",
keywords = "Contraceptive initiation, Emergency contraception, Oral contraceptives, Ovulation inhibition, Pharmacodynamics, Ulipristal acetate",
author = "Alison Edelman and Jeffrey Jensen and Sara McCrimmon and Marci Messerle-Forbes and Andrea O'Donnell and Jon Hennebold",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.contraception.2018.08.003",
language = "English (US)",
volume = "98",
pages = "463--466",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation

T2 - A prospective cohort study

AU - Edelman, Alison

AU - Jensen, Jeffrey

AU - McCrimmon, Sara

AU - Messerle-Forbes, Marci

AU - O'Donnell, Andrea

AU - Hennebold, Jon

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Objective: To determine if a combined oral contraceptive (COC) initiated shortly after ulipristal acetate (UPA) administration interferes with its mechanism of action. Study design: Healthy, reproductive-age women of normal BMI with proven ovulation (serum progesterone >3 ng/ml) were enrolled for three cycles (Cycle 1, UPA only; Cycle 2 washout; Cycle 3 UPA plus COC). During Cycles 1 and 3, subjects were monitored with transvaginal ultrasound and blood sampling for progesterone and LH every other day until a dominant follicle measuring >15 mm was visualized. In both treatment cycles, subjects received UPA (30mg) and were followed daily with similar monitoring for up to 7 days. In Cycle 3 only, subjects initiated a daily COC (0.15 mg levonorgestrel/30 μg ethinyl estradiol) 2 days after UPA. The study had 80% power to detect a 15% difference in the proportion of cycles with at least a 5-day delay in follicle rupture. We assessed follicle rupture as >50% decrease in mean size and adjudicated unclear outcomes with serum hormones. Results: A total of 36 women enrolled and 33 completed all study procedures [age 28.4 years (SD 3.9); BMI 23.4 (SD 2.4)]. Compared to Cycle 1, more subjects demonstrated evidence of follicle rupture in <5 days in Cycle 3 [1/33 (3%) vs. 9/33 (27%), p =.008]. We also included data from 2 subjects who experienced rupture prior to COC dosing in the analysis. Conclusion: UPA's effectiveness is significantly reduced by administering COCs 2 days later. Implications: This study demonstrates that UPA's efficacy as an emergency contraceptive is reduced with early exposure to COCs.

AB - Objective: To determine if a combined oral contraceptive (COC) initiated shortly after ulipristal acetate (UPA) administration interferes with its mechanism of action. Study design: Healthy, reproductive-age women of normal BMI with proven ovulation (serum progesterone >3 ng/ml) were enrolled for three cycles (Cycle 1, UPA only; Cycle 2 washout; Cycle 3 UPA plus COC). During Cycles 1 and 3, subjects were monitored with transvaginal ultrasound and blood sampling for progesterone and LH every other day until a dominant follicle measuring >15 mm was visualized. In both treatment cycles, subjects received UPA (30mg) and were followed daily with similar monitoring for up to 7 days. In Cycle 3 only, subjects initiated a daily COC (0.15 mg levonorgestrel/30 μg ethinyl estradiol) 2 days after UPA. The study had 80% power to detect a 15% difference in the proportion of cycles with at least a 5-day delay in follicle rupture. We assessed follicle rupture as >50% decrease in mean size and adjudicated unclear outcomes with serum hormones. Results: A total of 36 women enrolled and 33 completed all study procedures [age 28.4 years (SD 3.9); BMI 23.4 (SD 2.4)]. Compared to Cycle 1, more subjects demonstrated evidence of follicle rupture in <5 days in Cycle 3 [1/33 (3%) vs. 9/33 (27%), p =.008]. We also included data from 2 subjects who experienced rupture prior to COC dosing in the analysis. Conclusion: UPA's effectiveness is significantly reduced by administering COCs 2 days later. Implications: This study demonstrates that UPA's efficacy as an emergency contraceptive is reduced with early exposure to COCs.

KW - Contraceptive initiation

KW - Emergency contraception

KW - Oral contraceptives

KW - Ovulation inhibition

KW - Pharmacodynamics

KW - Ulipristal acetate

UR - http://www.scopus.com/inward/record.url?scp=85054548896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054548896&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2018.08.003

DO - 10.1016/j.contraception.2018.08.003

M3 - Article

C2 - 30118684

AN - SCOPUS:85054548896

VL - 98

SP - 463

EP - 466

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 6

ER -